![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, April 23, 2021 12:07:33 PM
Or maybe??????
https://www.kiniksa.com/our-pipeline/mavrilimumab/
All the GM-CSF inhibitors are intriguing because we know that severe Covid and death is caused by the cytokine GM-CSF. Lenzilumab is far ahead of the competition and lenzilumab has zero safety concerns. The other anti-GM-CSF drugs have had immunosuppression issues. So lenzilumab will be given an EUA now and maybe some other anti-GM-CSF drugs will get an EUA in a year if they can show good safety.
https://www.bbc.com/news/health-56352128
https://directorsblog.nih.gov/2021/04/13/mapping-severe-covid-19-in-the-lungs-at-single-cell-resolution/
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM